Preston Robert Tisch Brain Tumor Center at Duke

Preston Robert Tisch Brain Tumor Center at Duke Brain tumor center of excellence providing hope and innovative treatments for patients.

Now enrolling: the D2C7 + Anti-CD40 trial for patients with malignant glioma.This study is testing whether a targeted im...
12/05/2025

Now enrolling: the D2C7 + Anti-CD40 trial for patients with malignant glioma.

This study is testing whether a targeted immunotoxin (D2C7) combined with an immune- stimulating antibody (anti-CD40) can work together to kill tumor cells and activate the immune system. It’s a novel approach that aims to attack the tumor from both the inside and out.

To learn more about eligibility, visit https://clinicaltrials.gov/study/NCT05734560.

This holiday season, we invite you to celebrate and give back with the Preston Robert Tisch Brain Tumor Center at Duke. ...
12/02/2025

This holiday season, we invite you to celebrate and give back with the Preston Robert Tisch Brain Tumor Center at Duke. Our limited edition holiday ornament is a symbol of hope, progress, and the community that makes this work possible.

When you make a gift of one hundred dollars or more, you will receive this ornament as a special thank you for your generosity.

Your support helps us provide world class care for patients and families while advancing research that brings us closer to new treatments and cures. This ornament is more than a keepsake. It is a reminder of the difference you make.

To make your holiday gift, visit https://duke.is/BTCHoliday2025.

Advanced Practitioners, including Nurse Practitioners and Physician Associates, are essential members of our care team a...
12/01/2025

Advanced Practitioners, including Nurse Practitioners and Physician Associates, are essential members of our care team at the Preston Robert Tisch Brain Tumor Center at Duke. They provide specialized medical and supportive care for patients with brain tumors, helping manage symptoms, monitor treatment progress, and support patients through each step of their treatment.

Working closely with neuro oncologists, neurosurgeons, and the entire clinical team, Advanced Practitioners ensure continuity, education, and compassionate care for every patient and family.

Learn more about our team and approach to care at tischbraintumorcenter.duke.edu

11/28/2025

Skip the chaos and lines today and honor a loved one with a gift of hope at the Preston Robert Tisch Brain Tumor Center at Duke. Your gift will make thousands of brain tumor patients and families smile this holiday season!

This Thanksgiving, we take a moment to reflect on what truly matters: the people, the moments, and the shared commitment...
11/28/2025

This Thanksgiving, we take a moment to reflect on what truly matters: the people, the moments, and the shared commitment to hope that bring our community together.

At the Preston Robert Tisch Brain Tumor Center at Duke, we are profoundly grateful for our patients and families who show courage in the face of challenge, our caregivers who give so selflessly each day, and our dedicated physicians, nurses, researchers, and staff who work tirelessly to advance care and discovery. Each person plays a vital role in creating an environment of compassion, innovation, and strength.

As we gather in gratitude, we are reminded that progress in brain tumor care is made possible through collaboration, perseverance, and the belief that every effort brings us closer to new understanding and healing.

From all of us at the Preston Robert Tisch Brain Tumor Center, we wish you and your loved ones a peaceful and restorative Thanksgiving surrounded by warmth, kindness, and connection.

When Laura Gorski was treated for a brain tumor as a child, she never imagined that her experience would shape the path ...
11/26/2025

When Laura Gorski was treated for a brain tumor as a child, she never imagined that her experience would shape the path she walks today.

Years later, Laura returned to the Preston Robert Tisch Brain Tumor Center at Duke, this time not as a patient but as a member of the team caring for others. Her work in our pediatric program is rooted in gratitude, purpose, and a deep understanding of what families face.

Each day, Laura helps create the same environment of support and expertise that once carried her through. Her story reminds us that healing can inspire a lifetime of giving back.

Read Laura’s full story in the Patient Stories section on our website at https://tischbraintumorcenter.duke.edu/news/patient-purpose-laura-gorskis-story. 🩵🧠

Mindfulness can be a powerful tool for both brain tumor patients and their caregivers. From daily journaling to mindful ...
11/24/2025

Mindfulness can be a powerful tool for both brain tumor patients and their caregivers. From daily journaling to mindful walks and breathing breaks, small moments of calm can make a big difference in managing stress and emotional wellbeing.

Discover simple mindfulness techniques that can help you or your loved one feel more grounded, focused, and supported throughout the journey.

Read the full blog at tischbraintumorcenter.duke.edu/blog/mindfulness-techniques-brain-tumor-patients-and-caregivers

Gliosarcoma is a rare and aggressive brain tumor that develops in the central nervous system. It contains both glial and...
11/20/2025

Gliosarcoma is a rare and aggressive brain tumor that develops in the central nervous system. It contains both glial and connective tissue components, making it a unique variant of glioblastoma.

Although uncommon, gliosarcoma is treated using similar approaches to glioblastoma, including surgery, radiation, and chemotherapy. Researchers at the Preston Robert Tisch Brain Tumor Center at Duke continue to study new treatment strategies to improve outcomes for patients facing this diagnosis.

Learn more at tischbraintumorcenter.duke.edu

Caregivers are integral members of the care team who understand the challenges of a brain tumor diagnosis on a personal ...
11/17/2025

Caregivers are integral members of the care team who understand the challenges of a brain tumor diagnosis on a personal level. They bring perspective, advocacy, and a sense of continuity to the patient experience, helping ensure that care extends beyond the clinic and into everyday life.

Caregiving can be one of the most meaningful and demanding roles a person can take on. At the Preston Robert Tisch Brain...
11/14/2025

Caregiving can be one of the most meaningful and demanding roles a person can take on. At the Preston Robert Tisch Brain Tumor Center at Duke, we believe that caring for caregivers is just as important as caring for patients.

When someone you know is supporting a loved one through a brain tumor diagnosis, small acts of kindness can have a lasting impact. Offer to listen without judgment. Lend a hand with daily tasks or appointments. Encourage moments of rest, reflection, and connection. Sometimes even a few kind words can remind them that they are seen and supported.

Together, we can create a community where caregivers feel cared for too.

On November 8, we recognize World Radiography Day, honoring the vital role of medical imaging in brain tumor diagnosis a...
11/10/2025

On November 8, we recognize World Radiography Day, honoring the vital role of medical imaging in brain tumor diagnosis and treatment.

From MRI and CT scans to PET imaging and advanced techniques such as spectroscopy and tractography, radiology helps our team see what the eye cannot, guiding precise and compassionate care.

Join us in celebrating the radiologists, technologists, and imaging specialists whose expertise makes progress possible every day.

A new study at Duke is testing a combination of the targeted therapy vorasidenib and the immunotherapy pembrolizumab in ...
11/06/2025

A new study at Duke is testing a combination of the targeted therapy vorasidenib and the immunotherapy pembrolizumab in adults with recurrent or progressive IDH1-mutant glioma. The goal is to evaluate whether this experimental treatment can provide a safer and more effective option for patients.

Patients may be eligible if they are 18 or older, have a grade 2 or grade 3 IDH1 R132H glioma that has returned or progressed after radiation and/or chemotherapy, and are considering surgery.

Learn more about the study and eligibility by visiting https://clinicaltrials.gov/study/NCT05484622

Address

047 Baker House, Trent Drive
Durham, NC
27710

Alerts

Be the first to know and let us send you an email when Preston Robert Tisch Brain Tumor Center at Duke posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram